EYPT Chart
- 52-Week Range: $7.51 - $18.40
- Market Capitalization: $336.73M
- Short Percentage: 0%
- Target Price: $36.00
- Shares Outstanding: 34.05M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
EYPT released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)GlobeNewsWire | May 16th
- EyePoint Pharmaceuticals to Report First Quarter 2022 Financial Results on May 4, 2022GlobeNewsWire | April 27th
- EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)GlobeNewsWire | April 18th
- EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)GlobeNewsWire | March 16th
- EyePoint Pharmaceuticals Appoints Isabelle Lefebvre as Chief Regulatory OfficerGlobeNewsWire | March 7th
- EyePoint Pharmaceuticals to Report Fourth Quarter and Full-Year 2021 Financial Results on March 3, 2022GlobeNewsWire | February 24th
Company Info
Website: https://eyepointpharma.com
Address: 480 Pleasant Street, Watertown, MA, United States, 02472
Sector: Healthcare
Industry: Biotechnology
Full time employees: 122
Address: 480 Pleasant Street, Watertown, MA, United States, 02472
Sector: Healthcare
Industry: Biotechnology
Full time employees: 122
$EYPT added more calls on that drop
$EYPT I'm friggin bored. Just give us our money already
$EYPT Keep up the pressure.
$EYPT take us to the moon
lets goooooo
$EYPT I hate this company.
$EYPT buy and HODL
$EYPT taking off soon